High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy

被引：2
|
作者：
Mellgard, George S. [1 ]
Bhutani, Divaya [2 ]
Mapara, Markus Y. [2 ]
Maurer, Mathew S. [3 ]
Radhakrishnan, Jai [4 ]
Lentzsch, Suzanne [2 ]
Chakraborty, Rajshekhar [2 ]
机构：
[1] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[3] Columbia Univ, Div Cardiol, Irving Med Ctr, New York, NY USA
[4] Columbia Univ, Div Nephrol, Irving Med Ctr, New York, NY USA
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 08期
关键词：
LIGHT-CHAIN AMYLOIDOSIS; DEXAMETHASONE; INHIBITOR;
D O I：
10.1038/s41409-024-02301-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1181 / 1183
页数：3
相关论文
共 50 条
  • [21] High-Dose Melphalan and Autologous Hematopoietic Stem Cell Transplantation in Primary Amyloidosis: Single-Center Results
    Charlinski, G.
    Ziarkiewicz, M.
    Boguradzki, P.
    Wiater, E.
    Torosian, T.
    Dwilewicz-Trojaczek, J.
    Wiktor-Jedrzejczak, W.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (08) : 2877 - 2881
  • [22] High-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis: NYHA stage and number of involved organs are predictable for proceeding to high-dose therapy
    Schonland, S
    Hegenbart, U
    Dengler, J
    Benner, A
    Hundemer, M
    Bochtler, T
    Ho, A
    Goldschmidt, H
    BONE MARROW TRANSPLANTATION, 2006, 37 : S6 - S6
  • [23] Reduced Early Mortality with Daratumumab-Based Frontline Therapy in Systemic AL Amyloidosis- Experience from the Columbia Amyloidosis Multidisciplinary Program
    Chakraborty, Rajshekhar
    Bhutani, Divaya
    Mapara, Markus
    Reshef, Ran
    Maurer, Mathew S.
    Radhakrishnan, Jai
    Lentzsch, Suzanne
    BLOOD, 2023, 142
  • [24] An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis
    Sanchorawala, Vaishali
    Seldin, David C.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2007, 14 (04): : 261 - 269
  • [25] High-dose therapy and autologous stem cell transplantation (ASCT) for systemic AL amyloidosis (AL): A report on 16 cases.
    Moreau, P
    Facon, T
    Leblond, V
    Attal, M
    Caillot, D
    Nedellec, G
    Huynh, A
    Bataille, R
    Harousseau, JL
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 205 - 205
  • [26] Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review
    Mhaskar, Rahul
    Kumar, Ambuj
    Behera, Madhusmita
    Kharfan-Dabaja, Mohamed A.
    Djulbegovic, Benjamin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (08) : 893 - 902
  • [27] Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation
    Seldin, DC
    Anderson, JJ
    Sanchorawala, V
    Malek, K
    Wright, DG
    Quillen, K
    Finn, KT
    Berk, JL
    Dember, LM
    Falk, RH
    Skinner, M
    BLOOD, 2004, 104 (06) : 1888 - 1893
  • [28] High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators
    Pooja Phull
    Vaishali Sanchorawala
    Dina Brauneis
    J. Mark Sloan
    Omar K. Siddiqi
    Karen Quillen
    Shayna Sarosiek
    Bone Marrow Transplantation, 2019, 54 : 1304 - 1309
  • [29] Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis
    S Y Lee
    R S Meehan
    D C Seldin
    J M Sloan
    K Quillen
    A Shelton
    D Brauneis
    V Sanchorawala
    Bone Marrow Transplantation, 2016, 51 : 1318 - 1322
  • [30] High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators
    Phull, Pooja
    Sanchorawala, Vaishali
    Brauneis, Dina
    Sloan, J. Mark
    Siddiqi, Omar K.
    Quillen, Karen
    Sarosiek, Shayna
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1304 - 1309
12345